About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: January 09, 2013
    The United States is among the wealthiest nations in the world, but it is far from the healthiest. For many years, Americans have been dying at younger ages than people in almost all other high-income countries. To gain a better understanding of this problem, the NIH asked the National Research Council and the IOM to investigate potential reasons for the U.S. health disadvantage and to assess its larger implications. No single factor can fully explain the U.S. health disadvantage. Without action to reverse current trends, the health of Americans will probably continue to fall behind that of people in other high-income countries.
  • Released: December 20, 2012
    In 2011, the IOM released the report The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding, the first comprehensive compilation of what is known about the health of each of these groups at different stages of life. One of the recommendations in this report was that information on patients’ sexual orientation and gender identity should be collected in electronic health records, just as information on race and ethnicity is routinely collected. As the next step in exploring this recommendation, the IOM held a workshop on collecting sexual orientation and gender identity data in electronic health records.
  • Released: December 14, 2012
    Patients diagnosed with multidrug-resistant tuberculosis (MDR TB) face lengthy treatment regimens of two years or more with daily, directly observed treatment with second-line anti-TB drugs (SLDs) that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. Ensuring a reliable and affordable supply of high-quality SLDs is a complex public health intervention that, so far, has not been organized or implemented in a way that allows all providers and patients access to SLDs when they are needed. The IOM held a workshop on July 31 – August 1, 2012, to explore options and opportunities to improve the effectiveness of the global SLD supply chain in delivering drugs to patients.
  • Released: December 10, 2012
    The vast majority of microorganisms live in highly complex communities within which they lead intensely interactive lives—competing, cooperating, and forming associations with one another and with their living and nonliving host environments. Indeed, microbial communities are intricately intertwined with the biology of all ecosystems on Earth—from the extreme environments of the human gut to deep sea hydrothermal vents and the windswept plains of Antarctica. Despite these observations, very little is actually known about the factors and processes that influence community assembly, stability, and function. The IOM's Forum on Microbial Threats hosted a workshop to explore the emerging science and potential applications of the “social biology” of microbial communities.
  • Released: December 06, 2012
    Created in 2005, the California Institute for Regenerative Medicine (CIRM) has carried out its stem cell research mission at an ambitious pace, successfully and thoughtfully providing more than $1.3 billion in awards to 59 institutions. Given the rapid scientific advances in stem cell science, as well as CIRM’s own development, CIRM must now transition its scientific program and the nature of its partnerships to meet new needs. At the request of CIRM, the IOM independently reviewed its programs, operations and strategies since its beginning. This report offers recommendations aimed at assisting CIRM as it develops its plans to realize the clinical benefits of regenerative medicine and to build a sustainable platform that takes greatest advantage of its many achievements.
  • Released: November 20, 2012
    Since the 1996 IOM report, Telemedicine: A Guide to Assessing Telecommunications for Health Care, attention to telehealth has continued to grow in both the public and private sectors. Peer-reviewed journals and professional societies are devoted to telehealth, the federal government provides grant funding to promote the use of telehealth, and the private technology industry continues to develop new applications for telehealth. However, barriers remain to the use of telehealth. The IOM held a workshop to examine how the use of telehealth technology can fit into the U.S. health care system.
  • Released: November 08, 2012
    One of the many benefits of the U.S. food system is a safe, nutritious, and consistent food supply. However, the same system also creates significant environmental, public health, and other costs that generally are not captured in the retail price of food. A better understanding of the costs and benefits of the food system would help decision makers, researchers, and practitioners make informed business and management decisions that would expand the benefits of the U.S. food system even further. The IOM and the National Research Council held a workshop to explore the external costs of food, the methodologies for quantifying those costs, and the limitations of the methodologies.
  • Released: November 02, 2012
    Over the last century, the major causes of disease and death among Americans have changed, shifting from predominantly communicable diseases spread by germs to chronic ailments. This shift has been accompanied by a deeper understanding about what keeps people healthy or leaves them vulnerable to becoming ill. Despite their importance to preventing illness, determining the value of community-based interventions has proven difficult. This report proposes a framework to assess the value of community-based, non-clinical prevention policies and wellness strategies.
  • Released: November 02, 2012
    Over the last century, the major causes of disease and death among Americans have changed, shifting from predominantly communicable diseases spread by germs to chronic ailments. This shift has been accompanied by a deeper understanding about what keeps people healthy or leaves them vulnerable to becoming ill. Despite their importance to preventing illness, determining the value of community-based interventions has proven difficult. This report proposes a framework to assess the value of community-based, non-clinical prevention policies and wellness strategies.
  • Released: November 02, 2012
    Over the last century, the major causes of disease and death among Americans have changed, shifting from predominantly communicable diseases spread by germs to chronic ailments. This shift has been accompanied by a deeper understanding about what keeps people healthy or leaves them vulnerable to becoming ill. Despite their importance to preventing illness, determining the value of community-based interventions has proven difficult. This report proposes a framework to assess the value of community-based, non-clinical prevention policies and wellness strategies.
Kamagra Brausetabletten